Status:
UNKNOWN
Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome
Lead Sponsor:
Ain Shams University
Conditions:
C08.381.840.500.475
C08.381.840.500.737
Eligibility:
FEMALE
20-35 years
Phase:
PHASE4
Brief Summary
Prophylactic antenatal administration of corticosteroid enhance fetal lung maturity and reduce the probability of respiratory morbidity in preterm births. assessment of administration of four doses i...
Detailed Description
Term neonates born between (37-39 wks) by elective cesarean section are likely to develop respiratory distress syndrome more than neonates born by vaginal delivery, and this risk increases for the sub...
Eligibility Criteria
Inclusion
- Gestational age (37-39wks).
- Singleton pregnancy.
- Didn't receive any steroid treatment during pregnancy.
Exclusion
- Undetermined gestational age
- Maternal chronic diseases (e.g: hypertension, DM-2) to avoid any side effects of steroid use and to keep the pregnant 's case from getting worse.
- Congenital fetal malformations
- Emergency CS
- Pregnant refusing to participate in the study or unable to consent
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT04816097
Start Date
April 1 2021
End Date
April 1 2022
Last Update
March 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.